ClinicalTrials.Veeva

Menu

Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone

Medical University of Vienna logo

Medical University of Vienna

Status and phase

Completed
Phase 3

Conditions

Neovascular Age Related Macular Degeneration

Treatments

Other: PDT plus intravitreal triamcinolone

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Background: To identify characteristic morphological changes of the retina, their change over time and the association with visual function after combined photodynamic therapy (PDT) and intravitreal triamcinolone (IVTA).

Methods: In this retrospective study, 40 patients (40 eyes) were treated with PDT and same day IVTA. Optical coherence tomography (OCT), fluorescein angiography (FA) and evaluation of distance visual acuity (VA) were performed. Main outcome measures were the anatomical changes within intra- and subretinal compartments and their detailed analysis and grading.

Sex

All

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cnv secondary to age related macular degeneration

Exclusion criteria

  • glaucoma, diabetic retinopathy

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems